Huiling Wang

State Key Laboratory Of Biotherapy, 610041
Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Multimodal imaging-guided NIR-II photo-gas nanoplatform amplifies PD-1 blockade for synergistic TNBC therapy.

Multimodal imaging-guided NIR-II photo-gas nanoplatform amplifies PD-1 blockade for synergistic TNBC therapy.

Journal: Theranostics

Published: February 24, 2026

Distinct Inflammatory Cytotoxic T Lymphocyte Populations Mediate PD-1 Blockade-Induced Immune-Related Adverse Events in Multiple Organs.

Distinct Inflammatory Cytotoxic T Lymphocyte Populations Mediate PD-1 Blockade-Induced Immune-Related Adverse Events in Multiple Organs.

Journal: Cancer research

Published: July 16, 2025

Cancer stem cells: Bridging microenvironmental interactions and clinical therapy.

Cancer stem cells: Bridging microenvironmental interactions and clinical therapy.

Journal: Clinical and translational medicine

Published: April 25, 2025

LncRNA ELFN1-AS1 maintains the stemness of colorectal cancer by preventing ubiquitinated degradation of the hnRNPA1 protein.

LncRNA ELFN1-AS1 maintains the stemness of colorectal cancer by preventing ubiquitinated degradation of the hnRNPA1 protein.

Journal: Cellular and molecular life sciences : CMLS

Published: February 26, 2025

A novel membrane-bound interleukin-2 promotes NK-92 cell persistence and anti-tumor activity.

A novel membrane-bound interleukin-2 promotes NK-92 cell persistence and anti-tumor activity.

Journal: Oncoimmunology

Published: October 03, 2022

The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer.

The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer.

Journal: Frontiers in immunology

Published: September 16, 2022

Immune-based combination therapy for esophageal cancer.

Immune-based combination therapy for esophageal cancer.

Journal: Frontiers in immunology

Published: August 16, 2022

Reduced smooth muscle-fibroblasts transformation potentially decreases intestinal wound healing and colitis-associated cancer in ageing mice.

Reduced smooth muscle-fibroblasts transformation potentially decreases intestinal wound healing and colitis-associated cancer in ageing mice.

Journal: Signal transduction and targeted therapy

Published: August 04, 2022

A specific upregulated long noncoding RNA in colorectal cancer promotes cancer progression.

A specific upregulated long noncoding RNA in colorectal cancer promotes cancer progression.

Journal: JCI insight

Published: January 27, 2022

Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer.

Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer.

Journal: Oncogene

Published: June 13, 2021

Hypomethylation of GDNF family receptor alpha 1 promotes epithelial-mesenchymal transition and predicts metastasis of colorectal cancer.

Hypomethylation of GDNF family receptor alpha 1 promotes epithelial-mesenchymal transition and predicts metastasis of colorectal cancer.

Journal: PLoS genetics

Published: April 27, 2020

Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.

Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.

Journal: Theranostics

Published: February 27, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026